Loading…

Loading grant details…

Completed H2020 European Commission

POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment

€5.99M EUR

Funder European Commission
Recipient Organization Universiteit Utrecht
Country Netherlands
Start Date Apr 01, 2021
End Date Mar 31, 2025
Duration 1,460 days
Number of Grantees 15
Roles Participant; Coordinator
Data Source European Commission
Grant ID 964766
Grant Description

The POLYRISK project aims unraveling the risks of microplastic and nanoplastic particles (MNP) that are ubiquitous in our environment and are likely to be entering the human body via inhalation and ingestion.

The most bioavailable low-micron and nano-sized MNP, pose the biggest analytical challenges or today’s analytical chemists.

Existing knowledge about the adverse pro-inflammatory effects of airborne particulate matter and nanoparticles, combined with pro-inflammatory evidence of MNP exposure observed in animal models and in vitro pilot tests with human immune cells, suggests that MNP may cause immunotoxicity in humans.

Occupational exposure of workers to fibrous MNP can indeed lead to granulomatous lesions, causing respiratory irritation, functional abnormalities and flock worker’s lung. Currently, human health risk assessment protocols specific to MNP are not available and key data is missing.

This hampers science-based decision making.On this backdrop, POLYRISK’s human risk assessment strategy will combine highly advanced sampling, sample pretreatment and analytical methods to detect MNP in complex matrices, up-to-date fit-for-purpose hazard assessment technologies and multiple real-life human exposure scenarios.

We will focus on key toxic events linked to several chronic inflammatory diseases.

The consortium uniquely brings together interdisciplinary experience and know-how on quality-controlled chemical analyses of MNP and additives, intestinal and respiratory toxicity models, human exposure epidemiology, immunotoxicology and real-life high-exposure studies.

POLYRISK’s novel human risk assessment strategy is based on mechanistic reasoning and pragmatically accommodates the complexity of the MNP toxicant class.

Building with ground-breaking science, stakeholder engagement and strong communication, POLYRISK aims to rapidly reduce current MNP risk uncertainties and support EU efforts to ensure public health is adequately protected from the potential risks of MNP pollution. POLYRISK is a part of the European cluster on Health Impacts of Micro- and Nanoplastics.

All Grantees

Bundesinstitut Fuer Risikobewertung; Folkehelseinstituttet; Stichting Vu; Ideaconsult Limited Liability Company; Bundesanstalt Fuer Arbeitsschutz Und Arbeitsmedizin; Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung Ev; European Research Services Gmbh; Agenzia Nazionale Per Le Nuove Tecnologie, L'Energia E Lo Sviluppo Economico Sostenibile; Institutul National de Cercetare-Dezvoltare Pentru Textile Si Pielarie; Universitair Medisch Centrum Utrecht; Stichting Amsterdam Umc; Bundesanstalt Fuer Materialforschung Und -Pruefung; Universiteit Utrecht; Umweltbundesamt; Health and Environment Alliance

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant